DEFM14A: Pono Capital Two, Inc. Seeks Stockholder Approval for SBC Medical Group Merger

Pono Capital Two, Inc. is seeking stockholder approval for its proposed merger with SBC Medical Group Holdings Incorporated, outlined in a definitive proxy statement.

Summary

• Pono Capital Two, Inc. is seeking stockholder approval for a merger with SBC Medical Group Holdings Incorporated.
• The merger agreement, dated January 31, 2023, and amended several times, involves Pono's subsidiary merging into SBC, with SBC becoming a wholly-owned subsidiary of Pono.
• SBC securityholders will receive Pono securities valued at approximately $1,064,066,356, subject to adjustments for net working capital, indebtedness, and transaction expenses.
• Pono stockholders will vote on adopting the merger agreement, amending Pono's charter, electing directors, and approving an equity incentive plan and Nasdaq proposal.
• The special meeting is scheduled for August 23, 2024, and stockholders of record as of June 27, 2024, are entitled to vote.
• The Pono board recommends voting in favor of all proposals.

Sentiment

Score: 6

Explanation: The document is largely factual, presenting the details of the proposed merger. While there are positive aspects like the potential for growth, there are also risks and uncertainties, resulting in a neutral to slightly positive sentiment.

Positives

• The Pono board believes the merger is in the best interests of Pono and its stockholders.
• The merger provides SBC securityholders with access to the public markets.
• The combined company is expected to benefit from SBC's established business and growth potential.

Negatives

• The Sponsor, directors and officers of Pono have interests in the Business Combination that may conflict with your interests as a stockholder.
• The Combined Entity will be a controlled company within the meaning of the applicable rules of Nasdaq and, as a result, will qualify for exemptions from certain corporate governance requirements.
• The Merger Consideration is subject to a post-Closing true-up 90 days after the Closing.

Risks

• Redemptions by Pono stockholders could reduce the amount of cash available for the Business Combination.
• The Combined Entity will be a controlled company, potentially reducing corporate governance protections.
• The estimated Merger Consideration is subject to change based on SBC's net working capital, indebtedness, and transaction expenses at closing.
• The Sponsor, directors and officers of Pono have interests in the Business Combination that may conflict with your interests as a stockholder.
• The Combined Entity will be a controlled company within the meaning of the applicable rules of Nasdaq and, as a result, will qualify for exemptions from certain corporate governance requirements. If the Combined Entity relies on these exemptions, its stockholders will not have the same protections afforded to stockholders of companies that are subject to such requirements.

Future Outlook

The combined company will focus on providing quality comprehensive management services to the MCs and expand its Shonan Beauty Clinic brand by maintaining and strengthening its market position and brand in the cosmetic medical treatment management market in Japan, Vietnam, and the United States, and by growing our presence globally.

Management Comments

• The Pono Board has determined that each of the Proposals is fair to and in the best interests of Pono and its stockholders, and has approved such proposals.
• On behalf of the Pono Board, I would like to thank you for your support and look forward to the successful completion of the Business Combination.

Industry Context

The announcement reflects the ongoing trend of SPACs merging with private companies to bring them to the public market. The focus on the cosmetic medical treatment sector aligns with the growing demand for aesthetic services globally.

Comparison to Industry Standards

• The valuation multiples used in the analysis were based on comparable healthcare service companies, including Surgery Partners (Nasdaq: SGRY), National HealthCare (NYSE: NHC), Community Health (NYSE: CYH), and Encompass Health (NYSE: EHC).
• The back-office service companies used to determine the average earnings multiples include: WNS (Holdings) Limited (NYSE: WNS), ExlService Holdings, Inc. (Nasdaq: EXLS), Startek, Inc. (NYSE: SRT), TTEC Holdings, Inc. (Nasdaq: TTEC), Atento (Private Company), Conduent (Nasdaq: CNDT), and Taskus (Nasdaq: TASK).

Management Changes

Corporate Governance

Related Party Transactions

• The document discloses several related party transactions between SBC and its subsidiaries and related individuals and entities, including royalty income, rental services, and loans.
• The CEO of SBC is related to members of the medical corporations that SBC provides services to.

Stakeholder Impact

• Shareholders of Pono will have their shares converted into shares of the combined entity.
• Employees of SBC will become employees of the combined entity.
• Customers of SBC will continue to receive services from the combined entity.

Next Steps

• Pono stockholders will vote on the proposals at the special meeting on August 23, 2024.
• If approved, the Business Combination is expected to close shortly thereafter, subject to the satisfaction of remaining conditions.
• The combined company will then operate as SBC Medical Group Holdings Incorporated, trading on Nasdaq under the symbols SBC and SBCW.

Key Dates

Keywords

merger, SBC Medical Group, Pono Capital Two, proxy statement, stockholders, Business Combination, redemption, directors, charter amendment, incentive plan